EUVIMEDEUVIMED entdecken
Multizentrische Studie

Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms

Orly Leiva iD, Steven Soo, Nathaniel R Smilowitz iD, Harmony Reynolds iD, Binita Shah iD, Samuel Bernard iD, Joan How, Michelle Hyunju Lee iD, Gabriela Hobbs iD

Circulation: Cardiovascular Imaging · 2025

DOI: 10.1161/circimaging.124.017986 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Imaging, 2025. Verfasst von Orly Leiva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiology-Heart Failure, Department of Medicine, University of Chicago, IL (O.L.). Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Myeloproliferative Disorders, Echocardiography. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Myeloproliferative neoplasms (MPN) are a group of chronic leukemias that are associated with pulmonary hypertension (PH), which has been associated with increased risk adverse outcomes. The echocardiographic characterization of PH in MPN has not been reported, and the prognostic significance of PH among patients with MPN remains unclear. METHODS: This was a multicenter, retrospective cohort study of patients with MPN with ≥1 echocardiogram from 2010 to 2023. The echocardiographic probability of PH was determined according to the guidelines. The outcomes were hematologic progression and major adverse cardiovascular events. Exploratory analysis included outcomes among patients with right heart catheterization after the first echocardiogram, with PH defined as mean pulmonary artery pressure of >20 mm Hg. Multivariable Fine-Gray competing risk regression was used to estimate the subhazard ratio of hematologic progression and major adverse cardiovascular events. RESULTS: Five hundred fifty-five patients were included and 237 (42.7%) had an intermediate or high probability of PH on echocardiography. Over a median follow-up period of 51.2 months (interquartile range, 29.5–79.8), it was observed that echocardiographic probability of PH was associated with increased risk of hematologic progression (adjusted subhazard ratio, 1.92 [95% CI, 1.09–3.39]) and major adverse cardiovascular events (adjusted subhazard ratio, 1.66 [95% CI, 1.04–2.66]) but not all-cause death (adjusted hazard ratio, 1.51 [95% CI, 0.98–2.32]). Among patients with right heart catheterization (n=61), PH was present in 51 (83.6%) patients and was associated with a higher risk of hematologic progression (29.4% versus 0%; P =0.048). CONCLUSIONS: Among patients with MPN, echocardiographic probability of PH was associated with an increased risk of hematologic progression. Prospective studies are needed to assess the optimal use of echocardiography on MPN-specific prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryMyeloproliferative DisordersEchocardiographyHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisAgedRisk AssessmentDisease ProgressionRisk FactorsPredictive Value of Tests

Stichwörter der Autor:innen

cardio-oncologyechocardiographyhypertension, pulmonaryleukemia

Autor:innen und Institutionen

  • Section of Cardiology-Heart Failure, Department of Medicine, University of Chicago, IL (O.L.).
  • Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine (O.L., N.R.S., H.R., B.S., S.B.).
  • Department of Medicine, New York University Long Island School of Medicine, Mineola (S.S.).
  • Division of Hematology and Oncology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (J.H.).
  • Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (M.H.L., G.H.).

ORCID-Profile: Orly Leiva, Nathaniel R Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Gabriela Hobbs

Zitieren

APA

Leiva, O., Soo, S., Smilowitz, N. R., Reynolds, H., Shah, B., Bernard, S., How, J., Lee, M. H., & Hobbs, G. (2025). Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.124.017986

Vancouver

Leiva O, Soo S, Smilowitz NR, Reynolds H, Shah B, Bernard S, et al. Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms. Circulation: Cardiovascular Imaging. 2025. doi:10.1161/circimaging.124.017986

BibTeX
@article{Leiva2025,
  author = {Leiva, Orly and Soo, Steven and Smilowitz, Nathaniel R and Reynolds, Harmony and Shah, Binita and Bernard, Samuel and How, Joan and Lee, Michelle Hyunju and Hobbs, Gabriela},
  title = {Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2025},
  doi = {10.1161/circimaging.124.017986}
}
Kostenlos starten →